Home

Company

Products

Press

Purchase

Contact

Company Profile

• Biopharmaceutical company developing enhanced natural therapeutics for infectious diseases, cancer and and quality-of-life medicines

• Enhanced therapeutics include small molecules from medicinal plants and marine organisms, and improved drug delivery formulations of protein macromolecules and hydrophobic anticancer drugs

• Enabling technology platforms, nanotechnologies and therapeutic products covered by 29 issued U.S. and international patents, and several pending patent applications

• History of collaborations with multinational companies such as Novartis, Bayer, Bristol-Myers Squibb, Eli Lilly and the Gillette Company, and leading academic institutions

Product Pipeline

• Six lead therapeutic products being developed: an antidepressant, a benign prostatic hyperplasia product and four oncology products – LoTax™, a generic of the popular anticancer drug Taxol®, two improved drug delivery formulations of paclitaxel and Zindol™, an enhanced ginger product, in a Phase II/III clinical trial for nausea in cancer patients undergoing chemotherapy

• Rich pipeline of antiviral and antimicrobial therapeutics being researched

Business Strategy

• Collaborative R&D with strategic corporate partners to develop enhanced therapeutic products

• Licensure of enabling technology platforms for the discovery, delivery and development of small natural molecules and large protein macromolecules

• Direct product sales of active pharmaceutical ingredients (APIs) and finished products

For more information about Aphios Corporation, please click here.